Cited by 807Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseViral Infections and Immunology Research

The DOI matches its Crossref record; 518 of the 518 references it cites were found in a registry or an index.

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Ommen, Steve R., Ho, Carolyn Y., Asif, Irfan M., Balaji, Seshadri, Burke, Michael A., Day, Sharlene M., Dearani, Joseph A., Epps, Kelly C., Evanovich, Lauren, Ferrari, Victor A., Joglar, José A., Khan, Sadiya S., Kim, Jeffrey J., Kittleson, Michelle M., Krittanawong, Chayakrit, Martinez, Matthew W., Mital, Seema, Naidu, Srihari S., Saberi, Sara, Semsarian, Christopher, Times, Sabrina, Waldman, Cynthia Burstein·2024·Circulation

DOI 10.1161/cir.0000000000001250

Open this paper in CoChat — free account

Abstract

AIM: The “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy” provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy. METHODS: A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. STRUCTURE: Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the “2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy” have been updated with new evidence to guide clinicians.

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000001250

Cites

518 of 518 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Items 201–400 of 518

Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States
Maron, M. S., Hellawell, J. L., Lucove, J. C., Farzaneh‐Far, R., & Olivotto, I. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.02.044 · Cited by 170
Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy.
Udelson, J. E., Bonow, R. O., O’Gara, P. T., Maron, B. J., van Lingen, A., Bacharach, S. L., & Epstein, S. E. (1989) · Circulation · doi:10.1161/01.cir.79.5.1052 · Cited by 167
Echocardiographic Strain Imaging to Assess Early and Late Consequences of Sarcomere Mutations in Hypertrophic Cardiomyopathy
Ho, C. Y., Carlsen, C. M., Thune, J. J., Havndrup, O., Bundgaard, H., Farrohi, F., Rivero, J., Cirino, A. L., Andersen, P. S., Christiansen, M., et al. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.862128 · Cited by 166
Self-citation
Prediction of Thrombo-Embolic Risk in Patients with Hypertrophic Cardiomyopathy (HCM Risk-CVA)
Guttmann, O. P., Pavlou, M., O’Mahony, C., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., García‐Pavía, P., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.316 · Cited by 165
Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy
Fumagalli, C., Maurizi, N., Day, S. M., Ashley, E. A., Michels, M., Colan, S. D., Jacoby, D. L., Marchionni, N., Vincent-Tompkins, J., Ho, C. Y., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.4268 · Cited by 163
Self-citation
Diltiazem Treatment for Pre-Clinical Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers
Ho, C. Y., Lakdawala, N. K., Cirino, A. L., Lipshultz, S. E., Sparks, E. A., Abbasi, S. A., Kwong, R. Y. K., Antman, E. M., Semsarian, C., González, A., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.08.003 · Cited by 162
Self-citation
Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy
Thaman, R., Gimeno, J. R., Murphy, R. T., Kubo, T., Sachdev, B., Mogensen, J., Elliott, P. M., & McKenna, W. J. (2005) · Heart · doi:10.1136/hrt.2003.031161 · Cited by 161
Prevention of inappropriate therapy in implantable cardioverter-defibrillators
Theuns, D. A. M. J., Klootwijk, A., Goedhart, D. M., & Jordaens, L. J. L. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.039 · Cited by 161
A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy
O’Mahony, C., Tome, M., Lambiase, P. D., Pantazis, A. A., Dickie, S., McKenna, W. J., & Elliot, P. M. (2013) · Heart · doi:10.1136/heartjnl-2012-303271 · Cited by 159
Sudden Cardiac Death in National Collegiate Athletic Association Athletes: A 20-Year Study
Petek, B. J., Churchill, T. W., Moulson, N., Kliethermes‌, S., Baggish, A. L., Drezner, J. A., Patel, M. R., Ackerman, M. J., Kucera, K. L., Siebert, D. M., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.065908 · Cited by 158
Self-citation
Long-Term Outcomes of Combined Epicardial and Endocardial Ablation of Monomorphic Ventricular Tachycardia Related to Hypertrophic Cardiomyopathy
Dukkipati, S. R., d’Ávila, A., Soejima, K., Bala, R., Inada, K., Singh, S. M., Stevenson, W. G., Marchlinski, F. E., & Reddy, V. Y. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.110.957290 · Cited by 156
Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators
Lampert, R. J., Olshansky, B., Heidbüchel, H., Lawless, C. E., Saarel, E. V., Ackerman, M. J., Calkins, H. G., Estes, N. A. M., Link, M. S., Maron, B. J., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.027828 · Cited by 156
Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population
Swiryn, S., Orlov, M. V., Benditt, D. G., Dimarco, J., Lloyd‐Jones, D. M., Karst, E., Qu, F., Slawsky, M., Turkel, M., & Waldo, A. L. (2016) · Circulation · doi:10.1161/circulationaha.115.020252 · Cited by 154
Pregnancy related complications in women with hypertrophic cardiomyopathy
Thaman, R., Varnava, A. M., Hamid, M. S., Firoozi, S., Sachdev, B., Condon, M., Gimeno, J. R., Murphy, R. T., Elliott, P. M., & McKenna, W. J. (2003) · Heart · doi:10.1136/heart.89.7.752 · Cited by 150
Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience
FABER, L. (2004) · European Journal of Echocardiography · doi:10.1016/j.euje.2004.01.001 · Cited by 150
Progression of Myocardial Fibrosis Assessed With Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy
Todiere, G., Aquaro, G. D., Piaggi, P., Formisano, F., Barison, A., Masci, P. G., Strata, E., Bacigalupo, L., Marzilli, M., Pingitore, A., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.076 · Cited by 149
Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy
Coats, C. J., Rantell, K., Bartnik, A., Patel, A., Mist, B., McKenna, W. J., & Elliott, P. M. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.002248 · Cited by 148
Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications.
Ingles, J., Burns, C., Bagnall, R. D., Lam, L., Yeates, L., Sarina, T., Puranik, R., Briffa, T. G., Atherton, J. J., Driscoll, T., et al. (2017) · PubMed · doi:10.1161/circgenetics.116.001620 · Cited by 148
Self-citation
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy
Lampert, R., Ackerman, M. J., Marino, B. S., Burg, M., Ainsworth, B., Salberg, L., Tome Esteban, M. T., Ho, C. Y., Abraham, R., Balaji, S., et al. (2023) · JAMA Cardiology · doi:10.1001/jamacardio.2023.1042 · Cited by 148
Self-citation
Exercise Echocardiography in Asymptomatic HCM
Desai, M. Y., Bhonsale, A., Patel, P., Naji, P., Smedira, N. G., Thamilarasan, M., Lytle, B. W., & Lever, H. M. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2013.08.010 · Cited by 146
Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy
Raphael, C. E., Cooper, R. M., Parker, K. H., Collinson, J., Vassiliou, V. S., Pennell, D. J., de Silva, R., Hsu, L., Greve, A. M., Nijjer, S. S., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.07.751 · Cited by 145
Patient re-contact after revision of genomic test results: points to consider—a statement of the American College of Medical Genetics and Genomics (ACMG)
David, K. L., Best, R. G., Brenman, L. M., Bush, L. W., Deignan, J. L., Flannery, D. B., Hoffman, J. D., Holm, I. A., Miller, D. T., O'Leary, J. C., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0391-z · Cited by 145
Hypertrophic obstructive cardiomyopathy: Comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score
Ralph-Edwards, A. C., Woo, A., McCrindle, B. W., Shapero, J. L., Schwartz, L., Rakowski, H., Wigle, E. D., & Williams, W. G. (2004) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.08.047 · Cited by 144
Risk Factors and Mode of Death in Isolated Hypertrophic Cardiomyopathy in Children
Decker, J. A., Rossano, J. W., Smith, E. O., Cannon, B. C., Clunie, S. K., Gates, C. M., Jefferies, J. L., Kim, J. J., Price, J. F., Dreyer, W. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.051 · Cited by 141
Self-citation
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial
Ho, C. Y., Day, S. M., Axelsson, A., Russell, M. W., Zahka, K., Lever, H. M., Pereira, A. C., Colan, S. D., Margossian, R., Murphy, A. M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01505-4 · Cited by 139
Self-citation
Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial
Axelsson, A., Iversen, K. K., Vejlstrup, N. G., Ho, C. Y., Norsk, J. B., Langhoff, L., Ahtarovski, K. A., Corell, P., Havndrup, O., Jensen, M. K., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70241-4 · Cited by 138
Self-citation
Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy
Ingles, J., Sarina, T., Yeates, L., Hunt, L., Macciocca, I., McCormack, L., Winship, I., McGaughran, J. M., Atherton, J. J., & Semsarian, C. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.44 · Cited by 137
Self-citation
Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center
Hodges, K., Rivas, C. A. G., Aguilera, J., Borden, R., Alashi, A., Blackstone, E. H., Desai, M. Y., & Smedira, N. G. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.11.148 · Cited by 137
Penetrance of Hypertrophic Cardiomyopathy in Children and Adolescents
Jensen, M. K., Havndrup, O., Christiansen, M., Andersen, P. S., Diness, B. R., Raja, A. A., Skovby, F., Køber, L., & Bundgaard, H. (2012) · Circulation · doi:10.1161/circulationaha.111.090514 · Cited by 136
Results of Ventricular Septal Myectomy and Hypertrophic Cardiomyopathy (from Nationwide Inpatient Sample [1998–2010])
Panaich, S., Badheka, A. O., Chothani, A., Mehta, K. D., Patel, N., Deshmukh, A. J., Singh, V., Savani, G. T., Arora, S., Patel, N., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.075 · Cited by 135
Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy
Yetman, A. T., Hamilton, R. M., Benson, L. N., & McCrindle, B. W. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00493-8 · Cited by 134
Sudden Death in Childhood Cardiomyopathy
Bharucha, T., Lee, K. J., Daubeney, P. E. F., Nugent, A. W., Turner, C., Sholler, G. F., Robertson, T., Justo, R. N., Ramsay, J., Carlin, J. B., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.552 · Cited by 133
Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy
Batzner, A., Pfeiffer, B., Neugebauer, A., Aicha, D., Blank, C., & Seggewiss, H. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.064 · Cited by 132
The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy
Finocchiaro, G., Sheikh, N., Biagini, E., Papadakis, M., Maurizi, N., Sinagra, G., Pelliccia, A., Rapezzi, C., Sharma, S., & Olivotto, I. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.07.019 · Cited by 132
Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score–matched cohort
Nguyen, A. P., Schaff, H. V., Hang, D., Nishimura, R. A., Geske, J. B., Dearani, J. A., Lahr, B. D., & Ommen, S. R. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.08.062 · Cited by 128
Self-citation
Outcome of Mildly Symptomatic or Asymptomatic Obstructive Hypertrophic Cardiomyopathy
Sorajja, P., Nishimura, R. A., Gersh, B. J., Dearani, J. A., Hodge, D. O., Wiste, H. J., & Ommen, S. R. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.079 · Cited by 126
Self-citation
2019 AATS/ACC/ASE/SCAI/STS Expert Consensus Systems of Care Document: A Proposal to Optimize Care for Patients With Valvular Heart Disease
Nishimura, R. A., O’Gara, P. T., Bavaria, J. E., Brindis, R. G., Carroll, J. D., Kavinsky, C. J., Lindman, B. R., Linderbaum, J. A., Little, S. H., Mack, M. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.007 · Cited by 126
Physical Activity and Other Health Behaviors in Adults With Hypertrophic Cardiomyopathy
Reineck, E. A., Rolston, B., Bragg‐Gresham, J. L., Salberg, L. R., Baty, L., Kumar, S., Wheeler, M. T., Ashley, E. A., Saberi, S., & Day, S. M. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.12.018 · Cited by 125
Self-citation
Survival After Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy
Maron, M. S., Kalsmith, B. M., Udelson, J. E., Li, W., & DeNofrio, D. D. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.922872 · Cited by 125
Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis
Norrish, G., Cantarutti, N., Pissaridou, E., Ridout, D. A., Limongelli, G., Elliot, P. M., & Kaski, J. P. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317702519 · Cited by 125
Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience
Rastegar, H., Boll, G., Rowin, E. J., Dolan, N., Carroll, C., Udelson, J. E., Wang, W., Carpino, P., Maron, B. J., Maron, M. S., et al. (2017) · Annals of Cardiothoracic Surgery · doi:10.21037/acs.2017.07.07 · Cited by 124
The emerging role of the cardiac genetic counselor
Ingles, J., Yeates, L., & Semsarian, C. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.07.017 · Cited by 123
Self-citation
Long-Term Outcomes After Medical and Invasive Treatment in Patients With Hypertrophic Cardiomyopathy
Vriesendorp, P. A., Liebregts, M., Steggerda, R. C., Schinkel, A. F. L., Willems, R., ten Cate, F. J., Cleemput, J. V., ten Berg, J. M., & Michels, M. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.06.012 · Cited by 123
Implantable Cardioverter-Defibrillator Shocks
Borne, R. T., Varosy, P. D., & Masoudi, F. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.428 · Cited by 123
Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC)
Goland, S., van Hagen, I. M., Elbaz‐Greener, G., Elkayam, U., Shotan, A., Merz, W. M., Enar, S. Ç., Гайсин, И. Р., Pieper, P. G., Johnson, M. R., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx189 · Cited by 123
Establishment of Specialized Clinical Cardiovascular Genetics Programs: Recognizing the Need and Meeting Standards: A Scientific Statement From the American Heart Association
Ahmad, F., McNally, E. M., Ackerman, M. J., Baty, L., Day, S. M., Kullo, I. J., Madueme, P. C., Maron, M. S., Martinez, M. W., Salberg, L. R., et al. (2019) · Circulation Genomic and Precision Medicine · doi:10.1161/hcg.0000000000000054 · Cited by 123
Self-citation
Hypertrophic Cardiomyopathy–Related Sudden Cardiac Death in Young People in Ontario
Weissler‐Snir, A., Allan, K. S., Cunningham, K. S., Connelly, K. A., Lee, D. S., SPEARS, D. A., Rakowski, H., & Dorian, P. (2019) · Circulation · doi:10.1161/circulationaha.119.040271 · Cited by 123
Echocardiography in Hypertrophic Cardiomyopathy
Afonso, L., Bernal, J., Bax, J. J., & Abraham, T. P. (2008) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.09.002 · Cited by 122
Toronto Hypertrophic Cardiomyopathy Genotype Score for Prediction of a Positive Genotype in Hypertrophic Cardiomyopathy
Gruner, C., Ivanov, J., Care, M. E., Williams, L. K., Moravsky, G., Yang, H., Laczay, B., Siminovitch, K. A., Woo, A., & Rakowski, H. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.112.963363 · Cited by 122
Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis
Providencia, R., Elliott, P., Patel, K., McCready, J., Babu, G., Srinivasan, N., Bronis, K., Papageorgiou, N., Chow, A., Rowland, E., et al. (2016) · Heart · doi:10.1136/heartjnl-2016-309406 · Cited by 122
Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: safety and feasibility
Santangeli, P., Biase, L. D., Lakkireddy, D., Burkhardt, J. D., Pillarisetti, J., Michowitz, Y., Sánchez, J., Horton, R., Mohanty, P. K., Gallinghouse, G. J., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.05.022 · Cited by 121
Long-term propranolol therapy in muscular subaortic stenosis.
Adelman, A. G., Shah, P. M., Gramiak, R., & Wigle, E. D. (1970) · Heart · doi:10.1136/hrt.32.6.804 · Cited by 121
Longevity of Sprint Fidelis Implantable Cardioverter-Defibrillator Leads and Risk Factors for Failure
Hauser, R. G., Maisel, W. H., Friedman, P. A., Kallinen, L. M., Mugglin, A. S., Kumar, K., Hodge, D. O., Morrison, T. B., & Hayes, D. L. (2011) · Circulation · doi:10.1161/circulationaha.110.975219 · Cited by 121
Anticoagulation Regimens During Pregnancy in Patients With Mechanical Heart Valves: A Systematic Review and Meta-analysis
Xu, Z., Fan, J., Luo, X., Zhang, W., Ma, J., Lin, Y., Ma, S., Chen, X., Wang, Z., Ou, J., et al. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.11.005 · Cited by 121
Transapical Approach to Myectomy for Midventricular Obstruction in Hypertrophic Cardiomyopathy
Kunkala, M. R., Schaff, H. V., Nishimura, R. A., Abel, M., Sorajja, P., Dearani, J. A., & Ommen, S. R. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2013.04.073 · Cited by 119
Self-citation
Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: Results of a structured exercise training program in a cardiac rehabilitation center
Klempfner, R., Kamerman, T., Schwammenthal, E., Nahshon, A., Hay, I., Goldenberg, I., Dov, F., & Arad, M. (2013) · European Journal of Preventive Cardiology · doi:10.1177/2047487313501277 · Cited by 118
Prediction of Sarcomere Mutations in Subclinical Hypertrophic Cardiomyopathy
Captur, G., Lopes, L. R., Mohun, T. J., Patel, V., Li, C., Bassett, P., Finocchiaro, G., Ferreira, V. M., Tome, M., Muthurangu, V., et al. (2014) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.114.002411 · Cited by 115
Self-citation
Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy
Raja, A. A., Farhad, H., Valente, A. M., Couce, J.-P., Jefferies, J. L., Bundgaard, H., Zahka, K. G., Lever, H. M., Murphy, A. M., Ashley, E. A., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032966 · Cited by 115
Self-citation
Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy—mechanisms of obstruction and outcomes of reoperation
Cho, Y. H., Quintana, E., Schaff, H. V., Nishimura, R. A., Dearani, J. A., Abel, M., & Ommen, S. R. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.05.028 · Cited by 114
Self-citation
Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy
Ostman-Smith, I., Wettrell, G., Keeton, B., Holmgren, D., Ergander, U., Gould, S. J., Bowker, C. M., & Verdicchio, M. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn122 · Cited by 113
Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy
Eberly, L. A., Day, S. M., Ashley, E. A., Jacoby, D. L., Jefferies, J. L., Colan, S. D., Rossano, J. W., Semsarian, C., Pereira, A. C., Olivotto, I., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.4638 · Cited by 113
Self-citation
A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy
Gilligan, D. M., Chan, W., Joshi, J., Clarke, P., FLETCHER, A. E., Krikler, S. J., & Oakley, C. M. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90386-f · Cited by 112
Role of Mitral Valve Plication in the Surgical Management of Hypertrophic Cardiomyopathy
Balaram, S. K., Ross, R. E., Sherrid, M. V., Schwartz, G. S., Hillel, Z., Winson, G., & Swistel, D. G. (2012) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2012.06.008 · Cited by 112
Advanced Heart Failure With Preserved Systolic Function in Nonobstructive Hypertrophic Cardiomyopathy
Rowin, E. J., Maron, B. J., Kiernan, M. S., Casey, S. A., Feldman, D. S., Hryniewicz, K. M., Chan, R. H. M., Harris, K. M., Udelson, J. E., DeNofrio, D. D., et al. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001435 · Cited by 111
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events
Maurizi, N., Passantino, S., Spaziani, G., Girolami, F., Arretini, A., Targetti, M., Pollini, I., Tomberli, A., Pradella, S., Calabri, G. B., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.0789 · Cited by 111
Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood
Panza, J. A., & Maron, B. J. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90187-2 · Cited by 110
Catheter Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy
Santangeli, P., Biase, L. D., Themistoclakis, S., Raviele, A., Schweikert, R. A., Lakkireddy, D., Mohanty, P. K., Bai, R., Mohanty, S., Pump, A., et al. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000339 · Cited by 110
Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal disease
Grupper, A., Park, S. J., Pereira, N. L., Schettle, S. D., Gerber, Y., Topilsky, Y., Edwards, B. S., Daly, R. C., Stulak, J. M., Joyce, L. D., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.03.012 · Cited by 109
Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts
Lambiase, P. D., Gold, M. R., Hood, M., Boersma, L. V. A., Theuns, D. A. M. J., Burke, M. C., Weiss, R., Russo, A. M., Kääb, S., & Knight, B. P. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.01.001 · Cited by 108
Self-citation
Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy
Cui, H. Z., Schaff, H. V., Nishimura, R. A., Geske, J. B., Dearani, J. A., Lahr, B. D., & Ommen, S. R. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.05.053 · Cited by 108
Self-citation
Hypertrophic subaortic stenosis
Stenson, R. E., Flamm, M. D., Harrison, D. C., & Hancock, E. W. (1973) · The American Journal of Cardiology · doi:10.1016/0002-9149(73)90012-x · Cited by 107
Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Habib, M., Adler, A., Fardfini, K., Hoss, S., Hanneman, K. A., Rowin, E. J., Maron, M. S., Maron, B. J., Rakowski, H., & Chan, R. H. M. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.09.037 · Cited by 107
Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications
Vriesendorp, P. A., Schinkel, A. F. L., Cleemput, J. V., Willems, R., Jordaens, L. J. L. M., Theuns, D. A. M. J., van Slegtenhorst, M. A., de Ravel, T. J. L., ten Cate, F. J., & Michels, M. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.06.009 · Cited by 105
Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy
Marwick, T. H., Stewart, W. J., Lever, H. M., Lytle, B. W., Rosenkranz, E. R., Duffy, C. I., & Salcedo, E. E. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90359-u · Cited by 105
Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: Altered left ventricular loading or improved muscle inactivation?
Paulus, W. J., Lorell, B. H., Craig, W. E., Wynne, J., Murgo, J. P., & Grossman, W. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80235-6 · Cited by 104
Provocation of latent left ventricular outflow tract gradients with amyl nitrite and exercise in hypertrophic cardiomyopathy
Marwick, T. H., Nakatani, S., Haluska, B. A., Thomas, J. D., & Lever, H. M. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80416-0 · Cited by 103
Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy
Wang, W., Lian, Z., Rowin, E. J., Maron, B. J., Maron, M. S., & Link, M. S. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004604 · Cited by 103
Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment
Jipin Das, K., Ingles, J., Bagnall, R. D., & Semsarian, C. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.138 · Cited by 103
Self-citation
Role of Family History of Sudden Death in Risk Stratification and Prevention of Sudden Death With Implantable Defibrillators in Hypertrophic Cardiomyopathy
Bos, J. M., Maron, B. J., Ackerman, M. J., Haas, T. S., Sorajja, P., Nishimura, R. A., Gersh, B. J., & Ommen, S. R. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.06.077 · Cited by 102
Self-citation
Standards defining a ‘Heart Valve Centre’: ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint
Chambers, J. B., Prendergast, B., Iung, B., Rosenhek, R., Zamorano, J. L., Piérard, L., Modine, T., Falk, V., Kappetein, A. P., Pîbarot, P., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx370 · Cited by 101
Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking
Vigneault, D. M., Yang, E., Jensen, P. J., Tee, M., Farhad, H., Chu, L. C. H., Noble, J. A., Day, S. M., Colan, S. D., Russell, M. W. W., et al. (2018) · Radiology · doi:10.1148/radiol.2018180339 · Cited by 101
Self-citation
Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?
Lafrenière‐Roula, M., Bolkier, Y., Zahavich, L. A., Mathew, J., George, K., Wilson, J., Stephenson, E. A., Benson, L. N., Manlhiot, C., & Mital, S. R. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz396 · Cited by 101
Self-citation
Outcomes of Restrictive and Hypertrophic Cardiomyopathies After LVAD: An INTERMACS Analysis
Patel, S. R., Saeed, O., Naftel, D. C., Myers, S. L., Kirklin, J. K., Jorde, U. P., & Goldstein, D. J. (2017) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2017.09.011 · Cited by 100
Efficacy and proarrhythmia of oral sotalol in pediatric patients
Pfammatter, J. P., Paul, T., Lehmann, C., & Kallfelz, H. C. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00268-3 · Cited by 99
Discrepant Measurements of Maximal Left Ventricular Wall Thickness Between Cardiac Magnetic Resonance Imaging and Echocardiography in Patients With Hypertrophic Cardiomyopathy
Hindieh, W., Weissler‐Snir, A., Hammer, H., Adler, A., Rakowski, H., & Chan, R. H. M. (2017) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.117.006309 · Cited by 99
Communicating new knowledge on previously reported genetic variants
Aronson, S., Clark, E. H., Varugheese, M., Baxter, S. M., Babb, L. J., & Rehm, H. L. (2012) · Genetics in Medicine · doi:10.1038/gim.2012.19 · Cited by 98
Molecular profiling of dilated cardiomyopathy that progresses to heart failure
Burke, M. A., Chang, S., Wakimoto, H., Gorham, J., Conner, D. A., Christodoulou, D. C., Parfenov, M. G., DePalma, S. R., Eminaga, S., Konno, T., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86898 · Cited by 98
Self-citation
Management Implications of Massive Left Ventricular Hypertrophy in Hypertrophic Cardiomyopathy Significantly Underestimated by Echocardiography but Identified by Cardiovascular Magnetic Resonance
Maron, M. S., Lesser, J. R., & Maron, B. J. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.367 · Cited by 97
Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks
Desai, M. Y., OWENS, A. T., Geske, J. B., Wolski, K., Saberi, S., Wang, A., Sherrid, M. V., Cremer, P. C., Naidu, S. S., Smedira, N. G., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.062534 · Cited by 97
Self-citation
Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives
Norrish, G., Jager, J., Field, E., Quinn, E., Fell, H., Lord, E., Cicerchia, M., Ochoa, J. P., Cervi, E., Elliot, P. M., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.038846 · Cited by 94
Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy
Pasqualucci, D., Fornaro, A., Castelli, G., Rossi, A., Arretini, A., Chiriatti, C., Targetti, M., Girolami, F., Corda, M., Orrù, P., et al. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001843 · Cited by 93
Study Design and Rationale of EXPLORER-HCM
Ho, C. Y., Olivotto, I., Jacoby, D. L., Lester, S. J., Roe, M. T., Wang, A., Waldman, C. B., Zhang, D., Sehnert, A. J., & Heitner, S. B. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.006853 · Cited by 93
Self-citation
Vigorous exercise in patients with hypertrophic cardiomyopathy
Dejgaard, L. A., Haland, T. F., Lie, O. H., Ribe, M. P., Bjune, T., Leren, I. S., Berge, K. E., Edvardsen, T., & Haugaa, K. H. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.07.015 · Cited by 88
Exacerbation of cardiac energetic impairment during exercise in hypertrophic cardiomyopathy: a potential mechanism for diastolic dysfunction
Dass, S., Cochlin, L. E., Suttie, J. J., Holloway, C. J., Rider, O. J., Carden, L., Tyler, D. J., Karamitsos, T. D., Clarke, K., Neubauer, S., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv120 · Cited by 87
Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy: Table 1
Kaski, J. P., Tome, M., LOWE, M. D., Sporton, S. C., Rees, P. G., Deanfield, J. E., McKenna, W. J., & Elliot, P. M. (2006) · Heart · doi:10.1136/hrt.2006.094730 · Cited by 87
Targeting Percutaneous Transluminal Septal Ablation for Hypertrophic Obstructive Cardiomyopathy by Intraprocedural Echocardiographic Monitoring
Faber, L., Ziemssen, P., & Seggewiß, H. (2000) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2000.108250 · Cited by 87
Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy
Ong, K. C., Geske, J. B., Hebl, V. B., Nishimura, R. A., Schaff, H. V., Ackerman, M. J., Klarich, K. W., Siontis, K. C., Coutinho, T. A., Dearani, J. A., et al. (2016) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jew024 · Cited by 87
Self-citation
Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery
Qin, J. X., Shiiota, T., & Lever, H. M. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00561-5 · Cited by 87
Standing and Exercise Doppler Echocardiography in Obstructive Hypertrophic Cardiomyopathy: The Range of Gradients with Upright Activity
Joshi, S. A., Patel, U. K., Yao, S., Castenada, V., Isambert, A., Winson, G., Chaudhry, F. A., & Sherrid, M. V. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.10.006 · Cited by 86
Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy
Sorajja, P., Binder, J. S., Nishimura, R. A., Holmes, D. R., Rihal, C. S., Gersh, B. J., Bresnahan, J. F., & Ommen, S. R. (2012) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.24328 · Cited by 86
Self-citation
Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy
Mathew, J., Zahavich, L. A., Lafrenière‐Roula, M., Wilson, J., George, K., Benson, L. N., Bowdin, S. C., & Mital, S. R. (2017) · Clinical Genetics · doi:10.1111/cge.13157 · Cited by 86
Self-citation
Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis
Zhao, D.-S., Shen, Y., Zhang, Q., Lin, G., Lu, Y.-H., Chen, B.-T., Shi, L.-S., Huang, J.-F., & Lu, H.-H. (2015) · EP Europace · doi:10.1093/europace/euv339 · Cited by 85
Hypertrophic Cardiomyopathy as a Cause of Sudden Cardiac Death in the Young: A Meta-Analysis
Ullal, A. J., Abdelfattah, R. S., Ashley, E. A., & Froelicher, V. F. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.12.027 · Cited by 84
Risk Stratification and Role of Implantable Defibrillators for Prevention of Sudden Death in Patients With Hypertrophic Cardiomyopathy
Maron, B. J. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0921 · Cited by 84
Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers
Sweeting, J., Ingles, J., Timperio, A. F., Patterson, J. A., Ball, K., & Semsarian, C. (2016) · Open Heart · doi:10.1136/openhrt-2016-000484 · Cited by 84
Self-citation
Safety of Outpatient Initiation of Disopyramide for Obstructive Hypertrophic Cardiomyopathy Patients
Adler, A., Fourey, D., Weissler‐Snir, A., Hindieh, W., Chan, R. H. M., Gollob, M. H., & Rakowski, H. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005152 · Cited by 84
Long-Term Benefit of Myectomy and Anterior Mitral Leaflet Extension in Obstructive Hypertrophic Cardiomyopathy
Vriesendorp, P. A., Schinkel, A. F. L., Soliman, O. I. I., Kofflard, M. J. M., de Jong, P. L., van Herwerden, L. A., ten Cate, F. J., & Michels, M. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.12.017 · Cited by 83
Septal Myectomy Results in Regression of Left Ventricular Hypertrophy in Patients With Hypertrophic Obstructive Cardiomyopathy
Deb, S. J., Schaff, H. V., Dearani, J. A., Nishimura, R. A., & Ommen, S. R. (2004) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.05.063 · Cited by 83
Self-citation
Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy
Christiaans, I., Birnie, E., Bonsel, G. J., Mannens, M. M. A. M., Michels, M., Majoor-Krakauer, D., Dooijes, D., van Tintelen, J. P., van den Berg, M. P., Volders, P. G. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr092 · Cited by 83
Return-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death
Tobert, K. E., Bos, J. M., Garmany, R., & Ackerman, M. J. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.026 · Cited by 83
Effect of Spironolactone on Myocardial Fibrosis and Other Clinical Variables in Patients with Hypertrophic Cardiomyopathy
Maron, M. S., Chan, R. H. M., Kapur, N. K., Jaffe, I. Z., McGraw, A. P., Kerur, R., Maron, B. J., & Udelson, J. E. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.02.025 · Cited by 82
Concomitant Septal Myectomy at the Time of Aortic Valve Replacement for Severe Aortic Stenosis
Kayalar, N., Schaff, H. V., Daly, R. C., Dearani, J. A., & Park, S. J. (2010) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.10.065 · Cited by 81
Self-citation
Variability of Left Ventricular Outflow Tract Gradient During Cardiac Catheterization in Patients With Hypertrophic Cardiomyopathy
Geske, J. B., Sorajja, P., Ommen, S. R., & Nishimura, R. A. (2011) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2011.02.014 · Cited by 81
Self-citation
Cardiovascular collapse after verapamil in supraventricular tachycardia.
Kirk, R., Gibbs, J. L., Thomas, R. D., Radley-Smith, R., & Qureshi, S. (1987) · Archives of Disease in Childhood · doi:10.1136/adc.62.12.1265 · Cited by 81
Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy
Chen, M. S., McCarthy, P. M., Lever, H. M., Smedira, N. G., & Lytle, B. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.10.025 · Cited by 80
Cardiovascular consequences of myocardial bridging: A meta-analysis and meta-regression
Hostiuc, S., Rusu, M. C., Hostiuc, M., Negoi, R. I., & Negoi, I. (2017) · Scientific Reports · doi:10.1038/s41598-017-13958-0 · Cited by 80
Planned vaginal delivery and cardiovascular morbidity in pregnant women with heart disease
Easter, S. R., Rouse, C. E., Duarte, V. E., Hynes, J. S., Singh, M. N., Landzberg, M. J., Valente, A. M., & Economy, K. E. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.07.019 · Cited by 80
Development and Validation of a Clinical Predictive Model for Identifying Hypertrophic Cardiomyopathy Patients at Risk for Atrial Fibrillation: The HCM-AF Score
Carrick, R. T., Maron, M. S., Adler, A., Wessler, B. S., Hoss, S., Chan, R. H. M., Sridharan, A., Huang, D., Cooper, C., Drummond, J., et al. (2021) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009796 · Cited by 80
Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly
Östman‐Smith, I., Wettrell, G., Keeton, B. R., Riesenfeld, T., Holmgren, D., & Ergander, U. (2005) · Cardiology in the Young · doi:10.1017/s1047951105001824 · Cited by 79
Competitive Sport Participation Among Athletes With Heart Disease
Baggish, A. L., Ackerman, M. J., & Lampert, R. J. (2017) · Circulation · doi:10.1161/circulationaha.117.029639 · Cited by 79
Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy
van Velzen, H. G., Schinkel, A. F. L., Baart, S. J., Oldenburg, R. A., Frohn-Mulder, I. M. E., van Slegtenhorst, M. A., & Michels, M. (2018) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.117.001896 · Cited by 79
Hypertrophic remodelling in cardiac regulatory myosin light chain ( MYL2 ) founder mutation carriers
Claes, G. R. F., van Tienen, F. H. J., Lindsey, P. J., Krapels, I. P. C., den Enden, A. T. J. M. H.-V., Hoos, M. B., Barrois, Y. E. G., Janssen, J. W. H., Paulussen, A. D. C., Sels, J.-W. E. M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv522 · Cited by 78
Combined transaortic and transapical approach to septal myectomy in patients with complex hypertrophic cardiomyopathy
Hang, D., Schaff, H. V., Ommen, S. R., Dearani, J. A., & Nishimura, R. A. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.10.054 · Cited by 78
Self-citation
Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy and Apical Aneurysm
Igarashi, M., Nogami, A., Kurosaki, K., Hanaki, Y., Komatsu, Y., Fukamizu, S., Morishima, I., Kaitani, K., Nishiuchi, S., Talib, A. K., et al. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.12.020 · Cited by 78
Apical myectomy for patients with hypertrophic cardiomyopathy and advanced heart failure
Nguyen, A. P., Schaff, H. V., Nishimura, R. A., Geske, J. B., Dearani, J. A., King, K. S., & Ommen, S. R. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.03.088 · Cited by 78
Self-citation
Recent Innovations, Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Levine, G. N., O’Gara, P. T., Beckman, J. A., Al‐Khatib, S. M., Birtcher, K. K., Cigarroa, J. E., Fuentes, L. D. L., Deswal, A. M., Fleisher, L. A., Gentile, F., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000651 · Cited by 77
Self-citation
The Electrocardiogram as a Diagnostic Tool for Hypertrophic Cardiomyopathy: Revisited
Maron, B. J. (2001) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2001.tb00118.x · Cited by 76
Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy
Rowin, E. J., Maron, M. S., Chan, R. H. M., Hausvater, A., Wang, W., Rastegar, H., & Maron, B. J. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.08.048 · Cited by 76
Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study
Balaji, S., DiLorenzo, M. P., Fish, F. A., Etheridge, S. P., Aziz, P. F., Russell, M. W. W., Tisma‐Dupanovic, S., Pflaumer, A., Sreeram, N., Kubuš, P., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.04.040 · Cited by 76
Self-citation
Natural history of genotype positive–phenotype negative patients with hypertrophic cardiomyopathy
Gray, B. R., Ingles, J., & Semsarian, C. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.07.095 · Cited by 75
Self-citation
Clinical Experience of Subcutaneous and Transvenous Implantable Cardioverter Defibrillators in Children and Teenagers
Pettit, S., McLean, A. D., Colquhoun, I. W., Connelly, D. T., & McLEOD, K. A. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12233 · Cited by 74
Effect of Biventricular Pacing on Symptoms and Cardiac Remodelling in Patients with End-Stage Hypertrophic Cardiomyopathy
Rogers, D. P. S., Marazìa, S., CHOW, A. W. C., Lambiase, P. D., LOWE, M. D., Frenneaux, M. P., McKenna, W. J., & Elliot, P. M. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.03.006 · Cited by 74
Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: Managing the risk of procedure-related AV conduction disturbances
Faber, L., Welge, D., Faßbender, D., Schmidt, H. K., Horstkotte, D., & Seggewiß, H. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.07.179 · Cited by 74
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy
Jung, H., Yang, P., Jang, E., Yu, H. T., Kim, T., Uhm, J., Kim, J., Pak, H., Lee, M., Joung, B., et al. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.11.009 · Cited by 74
Self-citation
Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography
Bois, J. P., Geske, J. B., Foley, T. A., Ommen, S. R., & Pellikka, P. A. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.11.010 · Cited by 73
Self-citation
Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes
Kimmelstiel, C. D., Zisa, D. C., Kuttab, J. S., Wells, S. B., Udelson, J. E., Wessler, B. S., Rastegar, H., Kapur, N. K., WEINTRAUB, A. R., Maron, B. J., et al. (2019) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.118.007673 · Cited by 73
Successful Catheter Ablation of Hemodynamically Unstable Monomorphic Ventricular Tachycardia in a Patient with Hypertrophic Cardiomyopathy and Apical Aneurysm
Lim, K.-K., Maron, B. J., & Knight, B. P. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01366.x · Cited by 72
Utility of Isoproterenol to Provoke Outflow Tract Gradients in Patients With Hypertrophic Cardiomyopathy
Elesber, A. A., Nishimura, R. A., Rihal, C. S., Ommen, S. R., Schaff, H. V., & Holmes, D. R. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.09.111 · Cited by 72
Self-citation
Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study.
Toshima, H., Koga, Y., Nagata, H., Toyomasu, K., Itaya, K.-I., & Matoba, T. (1986) · Japanese Heart Journal · doi:10.1536/ihj.27.701 · Cited by 72
Interdisciplinary psychosocial care for families with inherited cardiovascular diseases
Caleshu, C. A., Kasparian, N. A., Edwards, K. S., Yeates, L., Semsarian, C., Perez, M. V., Ashley, E. A., Turner, C., Knowles, J. W., & Ingles, J. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.04.010 · Cited by 71
Self-citation
High Prevalence of Abnormal Nocturnal Oximetry in Patients With Hypertrophic Cardiomyopathy
Eleid, M. F., Konečný, T., Orban, M., Sengupta, P. P., Somers, V. K., Parish, J. M., Mookadam, F., Brady, P. A., Sullivan, B. L., Khandheria, B. K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.030 · Cited by 70
Self-citation
How to Image Hypertrophic Cardiomyopathy
Maron, M. S., Rowin, E. J., & Maron, B. J. (2017) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.116.005372 · Cited by 70
Impact of intraoperative transesophageal echocardiography in the surgical management of hypertrophic cardiomyopathy
Ommen, S. R., Park, S. H., Click, R. L., Freeman, W. K., Schaff, H. V., & Tajik, A. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02694-2 · Cited by 69
Self-citation
Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up
Dimitrow, P. P., Chojnowska, L., Rudziński, T., Piotrowski, W., Ziółkowska, L., Wojtarowicz, A., Wycisk, A., Dąbrowska-Kugacka, A., Nowalany-Kozielska, E., Sobkowicz, B., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq308 · Cited by 69
Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
Weinstock, J., Bader, Y. H., Maron, M. S., Rowin, E. J., & Link, M. S. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002488 · Cited by 69
Exercise Response in Hypertrophic Cardiomyopathy
Soullier, C., Obert, P., Doucende, G., Nottin, S., Cade, S., Pérez‐Martin, A., MESSNER-PELLENC, P., & Schuster, I. (2012) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.111.968859 · Cited by 69
Association of physical activity with all-cause and cardiovascular mortality in 7666 adults with hypertrophic cardiomyopathy (HCM): more physical activity is better
Kwon, S., Lee, H., Han, K., Kim, D. H., Seung-Pyo, L., Hwang, I., Yoon, Y. E., Park, J., Lee, H., Kwak, S., et al. (2020) · British Journal of Sports Medicine · doi:10.1136/bjsports-2020-101987 · Cited by 69
Self-citation
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
Norrish, G., Chen, Q., Field, E., Cervi, E., Khraiche, D., Klaassen, S., Ojala, T. H., Sinagra, G., Yamazawa, H., Marrone, C., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab181 · Cited by 69
Self-citation
Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy
Kato, T., Takayama, H., Yoshizawa, S., Marboe, C. C., Schulze, P. C., FARR, M. A., Naka, Y., MANCINI, D. M., & Maurer, M. S. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.04.030 · Cited by 67
Restrictive Physiology is Associated With Poor Outcomes in Children With Hypertrophic Cardiomyopathy
Maskatia, S. A., Decker, J. A., Spinner, J. A., Kim, J. J., Price, J. F., Jefferies, J. L., Dreyer, W. J., Smith, E. O., Rossano, J. W., & Denfield, S. W. (2011) · Pediatric Cardiology · doi:10.1007/s00246-011-0106-6 · Cited by 67
Self-citation
Does Sport Participation Worsen the Clinical Course of Hypertrophic Cardiomyopathy?
Pelliccia, A., Lemme, E., Maestrini, V., Paolo, F. M. D., Pisicchio, C., Gioia, G. D., & Caselli, S. (2018) · Circulation · doi:10.1161/circulationaha.117.031725 · Cited by 67
Blunted Myocardial Oxygenation Response During Vasodilator Stress in Patients With Hypertrophic Cardiomyopathy
Karamitsos, T. D., Dass, S., Suttie, J. J., Sever, E., Birks, J., Holloway, C. J., Robson, M. D., Jerosch‐Herold, M., Watkins, H. C., & Neubauer, S. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.12.024 · Cited by 66
Papillary Muscle Insertion Directly into the Anterior Mitral Leaflet in Hypertrophic Cardiomyopathy, Its Identification and Cause of Outflow Obstruction by Cardiac Magnetic Resonance Imaging, and Its Surgical Management
Rowin, E. J., Maron, B. J., Lesser, J. R., Rastegar, H., & Maron, M. S. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.340 · Cited by 66
Long-term outcome of nonobstructive versus obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis
Pelliccia, F., Pasceri, V., Limongelli, G., Autore, C., Basso, C., Corrado, D., Imazio, M., Rapezzi, C., Sinagra, G., & Mercuro, G. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.06.071 · Cited by 66
Sudden Cardiac Death Among Adolescents in the United Kingdom
Finocchiaro, G., Radaelli, D., D’Errico, S., Papadakis, M., Behr, E. R., Sharma, S., Westaby, J. D., & Sheppard, M. N. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.01.041 · Cited by 66
Heart Failure Progression in Hypertrophic Cardiomyopathy – Possible Insights From Cardiopulmonary Exercise Testing –
Magrì, D., Re, F., Limongelli, G., Agostoni, P., Zachara, E., Correale, M., Mastromarino, V., Santolamazza, C., Casenghi, M., Pacileo, G., et al. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0432 · Cited by 65
The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers
Ho, C. Y., Day, S. M., Colan, S. D., Russell, M. W. W., Towbin, J. A., Sherrid, M. V., Canter, C. E., Jefferies, J. L., Murphy, A. M., Cirino, A. L., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2016.5670 · Cited by 65
Self-citation
Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy?†
Nguyen, A. P., Schaff, H. V., Nishimura, R. A., Dearani, J. A., Geske, J. B., Lahr, B. D., & Ommen, S. R. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx398 · Cited by 65
Self-citation
Timing and Significance of Exercise-Induced Left Ventricular Outflow Tract Pressure Gradients in Hypertrophic Cardiomyopathy
Nistri, S., Olivotto, I., Maron, M. S., Grifoni, C., Baldini, K., Baldi, M., Sgalambro, A., Cecchi, F., & Maron, B. J. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.06.057 · Cited by 64
Determinants for Clinical Diagnosis of Hypertrophic Cardiomyopathy
Adabağ, S., Kuskowski, M. A., & Maron, B. J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.07.029 · Cited by 64
Mexiletine as an Adjunctive Therapy to Amiodarone Reduces the Frequency of Ventricular Tachyarrhythmia Events in Patients With an Implantable Defibrillator
Gao, D., Herendael, H. V., Alshengeiti, L., Dorian, P., Mangat, I., Korley, V. J., Ahmad, K., Golovchiner, G., Aves, T., & Pintér, A. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31829651fe · Cited by 64
Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta‐analysis
Osman, M., Kheiri, B., Osman, K., Barbarawi, M., Alhamoud, H., Alqahtani, F., & Alkhouli, M. A. (2018) · Clinical Cardiology · doi:10.1002/clc.23113 · Cited by 64
Impact of Hospital Volume on Outcomes of Septal Myectomy for Hypertrophic Cardiomyopathy
Holst, K. A., Schaff, H. V., Smedira, N. G., Habermann, E. B., Day, C. N., Badhwar, V., Takayama, H., McCarthy, P. M., & Dearani, J. A. (2022) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2022.05.062 · Cited by 64
Self-citation
A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy
Singh, K., Qutub, M. A., Carson‐Chahhoud, K., Hibbert, B. M., & Glover, C. A. (2015) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26293 · Cited by 63
A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy
Norrish, G., Ding, T., Field, E., McLEOD, K. A., Ilina, M. V., Stuart, G., Bhole, V., Uzun, O., Brown, E., Daubeney, P. E. F., et al. (2019) · EP Europace · doi:10.1093/europace/euz118 · Cited by 63
Comparison of Clinical Presentation, Left Ventricular Morphology, Hemodynamics, and Exercise Tolerance in Obese Versus Nonobese Patients With Hypertrophic Cardiomyopathy
Canepa, M., Sorensen, L. L., Pozios, I., Dimaano, V. L. J., Luo, H.-C., Pinheiro, A. C., Strait, J. B., Brunelli, C., Abraham, M. R., Ferrucci, L., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.05.070 · Cited by 62
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy
Maurizi, N., Michels, M., Rowin, E. J., Semsarian, C., Girolami, F., Tomberli, B., Cecchi, F., Maron, M. S., Olivotto, I., & Maron, B. J. (2019) · Circulation · doi:10.1161/circulationaha.118.037264 · Cited by 62
Self-citation
Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: An echographic study
Bourmayan, C., Razavi, A., Fournier, C., Dussaule, J., Baragan, J., Gerbaux, A., & Gay, J. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90357-6 · Cited by 61
Impact of Advanced Therapies for Improving Survival to Heart Transplant in Patients with Hypertrophic Cardiomyopathy
Rowin, E. J., Maron, B. J., Abt, P., Kiernan, M. S., Vest, A. R., Costantino, F., Maron, M. S., & DeNofrio, D. D. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.12.044 · Cited by 61
Interactions Between Sleep Disordered Breathing and Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
Konečný, T., Brady, P. A., Orban, M., Lin, G., Pressman, G. S., Lehár, F., Kára, T., Gersh, B. J., Tajik, A. J., Ommen, S. R., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.023 · Cited by 60
Self-citation
Apical Hypertrophic Cardiomyopathy: Prevalence and Correlates of Apical Outpouching
Binder, J. S., Jost, C. H. A., Klarich, K. W., Connolly, H. M., Tajik, A. J., Scott, C. G., Julsrud, P. R., Ehrsam, J.-E., Bailey, K. R., & Ommen, S. R. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2011.03.002 · Cited by 60
Self-citation
Surgical myectomy improves pulmonary hypertension in obstructive hypertrophic cardiomyopathy
Geske, J. B., Konečný, T., Ommen, S. R., Nishimura, R. A., Sorajja, P., Schaff, H. V., Ackerman, M. J., & Gersh, B. J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht537 · Cited by 60
Self-citation
Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography
Corona‐Villalobos, C. P., Sorensen, L. L., Pozios, I., Chu, L. C. H., Eng, J., Abraham, M. R., Abraham, T. P., Kamel, I. R., & Zimmerman, S. L. (2016) · International journal of cardiac imaging · doi:10.1007/s10554-016-0858-4 · Cited by 60
Reduced Risk for Inappropriate Implantable Cardioverter-Defibrillator Shocks With Dual-Chamber Therapy Compared With Single-Chamber Therapy
Kolb, C., Sturmer, M., Sick, P. B., Reif, S., Davy, J. M., Molon, G., SCHWAB, J. O., Mantovani, G., Dan, D., Lennerz, C., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.05.015 · Cited by 60
Clinical Significance of Late Gadolinium Enhancement in Patients <20 Years of Age With Hypertrophic Cardiomyopathy
Smith, B. M., Dorfman, A. L., Yu, S., Russell, M. W. W., Agarwal, P., Mahani, M. G., & Lu, J. C. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.12.034 · Cited by 59
Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: Detection of threatening myocardial necrosis distant from the septal target area
Faber, L., Seggewiß, H., Ziemssen, P., & Gleichmann, U. (1999) · Catheterization and Cardiovascular Interventions · doi:10.1002/(sici)1522-726x(199908)47:4 · Cited by 59
Sotalol for refractory arrhythmias in pediatric and young adult patients: Initial efficacy and long-term outcome
Tanel, R. E., Walsh, E. P., Lulu, J. A., & Saul, J. P. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90079-9 · Cited by 59
Cardiovascular Magnetic Resonance Characteristics in Children With Hypertrophic Cardiomyopathy
Chaowu, Y., Zhao, S., Ling, J., Li, L., & Fang, W. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000414 · Cited by 59
Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: Potential for refinement of current criteria
Desai, M. Y., Smedira, N. G., Dhillon, A. S., Masri, A., Wazni, O. M., Kanj, M., Sato, K., Thamilarasan, M., Popović, Z., & Lever, H. M. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.03.150 · Cited by 59
Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers
Groarke, J. D., Galazka, P. Z., Cirino, A. L., Lakdawala, N. K., Thune, J. J., Bundgaard, H., Orav, E. J., Levine, R. A., & Ho, C. Y. (2018) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jey095 · Cited by 59
Self-citation
Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy.
Fahmy, A., Rowin, E., Jaafar, N., Chan, R., Rodriguez, J., Nakamori, S., Ngo, L., Pradella, S., Zocchi, C., Olivotto, I., et al. (2023) · JACC Cardiovascular Imaging · doi:10.1016/j.jcmg.2023.05.003 · Cited by 59
Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy
Ziółkowska, L., Turska‐Kmieć, A., Petryka, J., & Kawalec, W. (2015) · Pediatric Cardiology · doi:10.1007/s00246-015-1298-y · Cited by 58
Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy
Bassiouny, M., Lindsay, B. D., Lever, H. M., Saliba, W. I., Klein, A. L., Banna, M., Abraham, J. M., Shao, M., Rickard, J., Kanj, M. H., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.042 · Cited by 58
Post-Prandial Upright Exercise Echocardiography in Hypertrophic Cardiomyopathy
Feiner, E. C., Arabadjian, M. E., Winson, G., Kim, B., Chaudhry, F. A., & Sherrid, M. V. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.079 · Cited by 58
Incidence of Device-Detected Atrial Fibrillation and Long-Term Outcomes in Patients With Hypertrophic Cardiomyopathy
van Velzen, H. G., Theuns, D. A. M. J., Yap, S., Michels, M., & Schinkel, A. F. L. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.08.092 · Cited by 58
Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation
Domínguez, F., Climent, V. E., Zorio, E., Ripoll‐Vera, T., Salazar‐Mendiguchía, J., García‐Pinilla, J. M., Urbano-Moral, J. Á., Fernández, X., López-Cuenca, D., Ajo, R., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.08.010 · Cited by 58
Clinical Spectrum and Management Implications of Left Ventricular Outflow Obstruction With Mild Ventricular Septal Thickness in Hypertrophic Cardiomyopathy
Rowin, E. J., Maron, B. J., Chokshi, A. D., Kannappan, M., Arkun, K., Wang, W., Rastegar, H., & Maron, M. S. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.06.055 · Cited by 58
Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death
Martinez, K. A., Bos, J. M., Baggish, A. L., Phelan, D. M. J., Tobert, K. E., Newman, D. B., Scherer, E., Petek, B. J., Ackerman, M. J., & Martinez, M. W. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.05.059 · Cited by 58
Self-citation
Intraoperative Two- and Three-Dimensional Transesophageal Echocardiography in Combined Myectomy-Mitral Operations for Hypertrophic Cardiomyopathy
Nampiaparampil, R. G., Swistel, D. G., Schlame, M., Sarić, M., & Sherrid, M. V. (2018) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2017.11.016 · Cited by 57
Accuracy of Jet Direction on Doppler Echocardiography in Identifying the Etiology of Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy
Hang, D., Schaff, H. V., Nishimura, R. A., Lahr, B. D., Abel, M., Dearani, J. A., & Ommen, S. R. (2018) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2018.10.011 · Cited by 57
Self-citation
Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion
Kuhn, H. J. (1999) · European Heart Journal · doi:10.1053/euhj.1999.1692 · Cited by 56
Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications
Link, M. S., Bockstall, K. E., Weinstock, J., Alsheikh-Ali, A. A. A., Semsarian, C., Estes, N. A. M., Spirito, P., Haas, T. S., Rowin, E. J., Maron, M. S., et al. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13194 · Cited by 56
Self-citation
Outcomes in Patients With Hypertrophic Cardiomyopathy Awaiting Heart Transplantation
Cisneros, J. Z., Stehlik, J., Selzman, C. H., Drakos, S. G., McKellar, S. H., & Wever‐Pinzon, O. (2018) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004378 · Cited by 56
Determinants of Reverse Remodeling of the Left Atrium After Transaortic Myectomy
Nguyen, A. P., Schaff, H. V., Nishimura, R. A., Dearani, J. A., Geske, J. B., Lahr, B. D., & Ommen, S. R. (2018) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2018.03.039 · Cited by 56
Self-citation
Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable—Prévention Primaire registry
Defaye, P., Bovéda, S., Klug, D., Beganton, F., Piot, O., Narayanan, K., Perier, M., Gras, D., Fauchier, L., Bordachar, P., et al. (2017) · EP Europace · doi:10.1093/europace/euw230 · Cited by 55
Septal Myectomy in Hypertrophic Cardiomyopathy: National Outcomes of Concomitant Mitral Surgery
Holst, K. A., Hanson, K. T., Ommen, S. R., Nishimura, R. A., Habermann, E. B., & Schaff, H. V. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.07.022 · Cited by 55
Self-citation
Long-Term Follow-Up of Children and Adolescents Diagnosed with Hypertrophic Cardiomyopathy: Risk Factors for Adverse Arrhythmic Events
Moak, J. P., Leifer, E., Tripodi, D. J., MOHIDDIN, S. A., & Fananapazir, L. (2011) · Pediatric Cardiology · doi:10.1007/s00246-011-9967-y · Cited by 54
High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device
Wilke, I., Witzel, K., Münch, J., Pecha, S., Blankenberg, S., Reichenspurner, H. C., Willems, S., Patten, M., & Aydın, A. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12982 · Cited by 54
Molecular Autopsy for Sudden Unexpected Death
Torkamani, A., Muse, E. D., Spencer, E. G., Rueda, M., Wagner, G. N., Lucas, J. R., & Topol, E. J. (2016) · JAMA · doi:10.1001/jama.2016.11445 · Cited by 54
Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design
TANG, A. S. L., Wells, G. A., Arnold, M., Connolly, S. J., Hohnloser, S. H., Nichol, G., Rouleau, J. L., Sheldon, R. S., & Talajic, M. R. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32831bc63b · Cited by 53

Research works printed but not linked: 227

Committee on Standards for Systematic Reviews of Comparative Effectiveness Research Institute of Medicine (US). Finding What Works in Health Care: Standards for Systematic Reviews. National Academies Press; 2011.
Animal Studies-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/54.
Guidelines-Broad-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/75.
Guidelines-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/77.
RCT/ CCT-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/108.
SR/ MA/ HTA/ ITC-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022: Accessed September 14, 2022. https://searchfilters.cadth.ca/link/99.
10.1016/s0025-6196(11)64198-0 · DOI
10.1016/j.jacc.2014.05.003 · DOI · Paper page
10.1056/nejmra1710575 · DOI · Paper page
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1001/jamacardio.2015.0354 · DOI · Paper page
10.1056/nejmra1710575 · DOI · Paper page
10.1016/j.jacc.2015.01.019 · DOI
10.1016/j.jacc.2014.05.003 · DOI · Paper page
10.1016/j.jacc.2018.10.007 · DOI
10.1016/j.echo.2010.10.006 · DOI
10.1161/circulationaha.106.644682 · DOI
10.1016/j.amjcard.2017.08.047 · DOI
10.1093/ehjci/jew313 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1016/j.jacc.2013.02.079 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.01.071 · DOI
10.1016/j.jacc.2012.03.076 · DOI
10.1016/j.jacc.2010.11.002 · DOI
10.1016/j.echo.2011.03.006 · DOI
10.1161/circulationaha.107.698985 · DOI
10.1016/j.jcin.2011.02.014 · DOI
10.1016/j.amjcard.2007.09.111 · DOI
10.1161/01.cir.0000097110.55312.bf · DOI
10.1016/j.echo.2010.10.006 · DOI
10.1161/circulationaha.106.644682 · DOI
10.1016/j.amjcard.2017.08.047 · DOI
10.1093/ejechocard/jeq063 · DOI
10.1093/ehjci/jew313 · DOI
10.1136/hrt.2007.126003 · DOI
10.1056/nejmoa021332 · DOI · Paper page
10.1016/s0002-9149(99)80416-0 · DOI
10.1161/01.cir.0000162460.36735.71 · DOI
10.1016/j.jacc.2013.02.079 · DOI
10.1161/hcg.0000000000000054 · DOI
10.1093/eurheartj/ehq271 · DOI
10.1016/j.jacc.2012.02.068 · DOI
10.1161/circgen.117.001896 · DOI · Paper page
10.1161/circulationaha.114.013478 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1016/j.hrthm.2011.07.017 · DOI
10.1161/circulationaha.111.090514 · DOI
10.1161/circgenetics.116.001620 · DOI
10.1161/circulationaha.118.038846 · DOI
10.1016/j.jacc.2015.01.019 · DOI
10.1161/circulationaha.111.090514 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1161/circulationaha.118.037264 · DOI
10.1161/circulationaha.118.038846 · DOI
10.1016/j.jpeds.2017.03.033 · DOI
10.1093/eurheartj/ehr092 · DOI · Paper page
10.1148/radiol.2018180339 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1007/s10554-016-0858-4 · DOI
10.1016/j.amjcard.2016.11.010 · DOI
10.1016/j.amjcard.2010.01.367 · DOI
10.1016/j.jcmg.2016.02.031 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jacc.2018.05.060 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1016/j.echo.2011.03.002 · DOI
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1161/circulationaha.120.047235 · DOI
10.1111/cge.13157 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1093/europace/euz118 · DOI
10.1161/circulationaha.122.062699 · DOI
10.1161/circulationaha.120.047235 · DOI
10.1001/jamacardio.2019.2861 · DOI
10.1001/jamacardio.2018.0789 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1093/europace/euz118 · DOI
10.1177/2047487317702519 · DOI
10.1161/circheartfailure.113.000414 · DOI
10.1016/j.amjcard.2013.12.034 · DOI
10.1111/chd.12286 · DOI
10.1093/eurjpc/zwab181 · DOI
10.1016/j.jacc.2015.03.552 · DOI
10.1111/cge.13157 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/j.jjcc.2014.02.011 · DOI
10.1007/s10554-016-0858-4 · DOI
10.1016/j.amjcard.2016.11.010 · DOI
10.1016/j.amjcard.2010.01.367 · DOI
10.1016/j.jcmg.2016.02.031 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jacc.2018.05.060 · DOI
10.1001/jamacardio.2019.1391 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1016/j.jacc.2020.04.045 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1161/circulationaha.122.062699 · DOI
10.1016/s0735-1097(99)00056-x · DOI
10.1016/j.amjcard.2010.06.077 · DOI · Paper page
10.1056/nejm200006153422403 · DOI
10.1016/s0140-6736(00)04005-8 · DOI
10.1161/circulationaha.108.798314 · DOI · Paper page
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1017/s1047951105001824 · DOI
10.1038/nrcardio.2017.6 · DOI
10.1001/jamacardio.2019.1391 · DOI
10.1001/jama.298.4.405 · DOI
10.1016/j.ahj.2013.06.009 · DOI
10.1016/s0735-1097(99)00056-x · DOI
10.1161/circulationaha.108.798314 · DOI · Paper page
10.1016/j.amjcard.2010.06.077 · DOI · Paper page
10.1093/eurheartj/ehq308 · DOI
10.1056/nejm200006153422403 · DOI
10.1016/j.jacc.2004.12.067 · DOI
10.1016/s0140-6736(00)04005-8 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/j.jjcc.2014.02.011 · DOI
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1093/eurheartj/eht439 · DOI · Paper page
10.1016/j.jacc.2020.04.045 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1016/j.jacc.2013.01.037 · DOI
10.1177/2047487317702519 · DOI
10.1007/s00246-011-9967-y · DOI
10.1016/s0735-1097(98)00493-8 · DOI
10.1016/j.jacc.2015.03.552 · DOI
10.1007/s00246-013-0676-6 · DOI
10.1161/circulationaha.115.017633 · DOI
10.1161/circulationaha.120.047235 · DOI
10.1093/eurjpc/zwab181 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jcmg.2016.02.031 · DOI
10.1016/j.jacc.2018.05.060 · DOI
10.1016/j.amjcard.2013.12.034 · DOI
10.1161/circulationaha.112.136085 · DOI · Paper page
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1016/j.amjcard.2020.04.042 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1016/j.jacc.2009.03.051 · DOI
10.1016/j.jacc.2013.01.037 · DOI
10.1161/cir.0000000000001063 · DOI · Paper page
10.1161/cir.0000000000000628 · DOI · Paper page
10.1161/circulationaha.106.644682 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1016/j.jacc.2015.06.1333 · DOI · Paper page
10.1161/circulationaha.106.644682 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1016/j.amjcard.2013.01.340 · DOI
10.1016/j.jcmg.2013.08.010 · DOI
10.1001/jamacardio.2016.0252 · DOI
10.1016/j.jtcvs.2018.11.148 · DOI
10.1016/j.mayocp.2018.07.022 · DOI
10.1016/j.jacc.2016.07.735 · DOI · Paper page
10.1016/j.echo.2018.10.011 · DOI
10.1136/hrt.2007.118018 · DOI
10.1161/circulationaha.117.029267 · DOI · Paper page
10.1161/01.cir.0000162460.36735.71 · DOI
Liebregts, M, Vriesendorp, PA, Mahmoodi, BK, et al. A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol HF. 2015;3:896–905.
10.1536/ihj.27.701 · DOI
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1161/01.cir.0000097110.55312.bf · DOI
10.1161/cir.0000000000001063 · DOI · Paper page
10.1161/circulationaha.105.583500 · DOI
10.1093/eurheartj/ehq136 · DOI
10.1161/circheartfailure.114.002248 · DOI · Paper page
10.1253/circj.cj-16-0432 · DOI
10.1016/j.amjcard.2017.12.044 · DOI
10.1016/s0140-6736(20)31792-x · DOI · Paper page
10.1016/j.jacc.2020.04.045 · DOI
10.1016/j.ejheart.2008.03.006 · DOI
Gu, M, Jin, H, Hua, W, et al. Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy. J Geriatr Cardiol. 2017;14:238–244.
10.1016/j.jacc.2017.11.040 · DOI
10.1093/europace/euw327 · DOI
Rowin, EJ, Mohanty, S, Madias, C, et al. Benefit of cardiac resynchronization therapy in end-stage nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol EP. 2019;5:131–133.
10.1136/heartjnl-2013-305471 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1161/circheartfailure.114.001843 · DOI · Paper page
10.1016/s2213-8587(14)70241-4 · DOI
10.1016/j.amjcard.2016.08.092 · DOI
10.1111/jce.12982 · DOI
10.1161/circulationaha.117.029267 · DOI · Paper page
10.1016/j.jacc.2005.01.012 · DOI · Paper page
10.1161/jaha.116.005152 · DOI
10.1016/j.amjcard.2003.10.025 · DOI
10.1016/j.amjcard.2017.12.044 · DOI
10.1161/circheartfailure.114.001435 · DOI
10.1161/circep.110.957290 · DOI

200 of 227 shown

Sorted by citations

JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 275
2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation, treatment, and return to play
Lampert, R., Chung, E. H., Ackerman, M. J., Arroyo, A. R., Darden, D., Deo, R., Dolan, J., Etheridge, S. P., Gray, B. R., Harmon, K. G., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.05.018 · Cited by 167
Self-citation
HF STATS 2025: Heart Failure Epidemiology and Outcomes Statistics An Updated 2025 Report from the Heart Failure Society of America
Fonarow, G. C., Ahmad, F. S., Ahmad, T. A., Albert, N. M., Alexander, K. M., Baker, W. L., Bozkurt, B., Breathett, K. K., Carter, S. J., Cheng, R. K.-H., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.07.007 · Cited by 103
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Ndumele, C. E., Rodríguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M. S., Bangalore, S., Bozkurt, B., Breathett, K. K., Clarke, S. L., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001453 · Cited by 101
Self-citation
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC · doi:10.1016/j.jacc.2026.03.056 · Cited by 90
Self-citation

See all 807

Authors: Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., Joglar, J. A., Khan, S. S., Kim, J. J., Kittleson, M. M., Krittanawong, C., Martinez, M. W., Mital, S., Naidu, S. S., Saberi, S., Semsarian, C., Times, S., & Waldman, C. B.
Affiliations: American Medical Society for Sports Medicine (US)
HRS representative.
Lay stakeholder representative.
AHA/ACC Joint Committee on Clinical Practice Guidelines liaison.
American Hospital Association (US)
PACES representative.
Joint ACC/AHA staff representative.
ORCID: Ommen, Steve R.
Ho, Carolyn Y.
Asif, Irfan M.
Balaji, Seshadri
Burke, Michael A.
Day, Sharlene M.
Dearani, Joseph A.
Ferrari, Victor A.
Joglar, José A.
Khan, Sadiya S.
Kim, Jeffrey J.
Kittleson, Michelle M.
Krittanawong, Chayakrit
Martinez, Matthew W.
Mital, Seema
Naidu, Srihari S.
Saberi, Sara
Semsarian, Christopher
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2024-06-04
Volume: 149
Issue: 23
Pages: e1239-e1311
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/cir.0000000000001250
OpenAlex: W4396750647
Cited by: 807
References: 514
Citations by year: 2026: 353 · 2025: 372 · 2024: 82
FWCI: 226.55
Type: journal article
Language: en
Update notices: correction (2024-08-19)
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords: hypertrophic cardiomyopathy, disease management, inherited heart disease, diagnosis, treatment guidelines, American Heart Association, American College of Cardiology, American Society of Echocardiography
MeSH terms: American Heart Association, Cardiology, Cardiomyopathy, Hypertrophic, Humans, United States, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks